UBS Group’s Allied Healthcare Products AHPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,466
| Closed | -$6.87K | – | 11432 |
|
|
2022
Q4 | $6.87K | Buy |
+7,466
| New | +$8.79K | ﹤0.01% | 8976 |
|
|
2022
Q2 | – | Sell |
-1,220
| Closed | -$4K | – | 11462 |
|
|
2022
Q1 | $4K | Buy |
+1,220
| New | +$4.3K | ﹤0.01% | 9386 |
|
|
2021
Q4 | – | Sell |
-1,006
| Closed | -$7K | – | 11075 |
|
|
2021
Q3 | $7K | Sell |
1,006
-4,220
| -81% | -$32.8K | ﹤0.01% | 8365 |
|
|
2021
Q2 | $22K | Buy |
5,226
+1,864
| +55% | +$7.94K | ﹤0.01% | 7249 |
|
|
2021
Q1 | $16K | Buy |
3,362
+3,003
| +836% | +$17.1K | ﹤0.01% | 7595 |
|
|
2020
Q4 | $2K | Buy |
+359
| New | +$1.84K | ﹤0.01% | 8153 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$1K | – | 8601 |
|
|
2020
Q2 | $1K | Sell |
100
-1,194
| -92% | -$14.2K | ﹤0.01% | 7843 |
|
|
2020
Q1 | $23K | Sell |
1,294
-2,234
| -63% | -$17.4K | ﹤0.01% | 6417 |
|
|
2019
Q4 | $4K | Buy |
3,528
+3,255
| +1,192% | +$3.75K | ﹤0.01% | 7697 |
|
|
2019
Q3 | $0 | Sell |
273
-2,400
| -90% | -$3.67K | ﹤0.01% | 8382 |
|
|
2019
Q2 | $5K | Sell |
2,673
-5,715
| -68% | -$10.1K | ﹤0.01% | 7407 |
|
|
2019
Q1 | $15K | Buy |
8,388
+6,957
| +486% | +$13K | ﹤0.01% | 6560 |
|
|
2018
Q4 | $3K | Sell |
1,431
-2,431
| -63% | -$4.92K | ﹤0.01% | 7753 |
|
|
2018
Q3 | $9K | Buy |
3,862
+2,161
| +127% | +$5.21K | ﹤0.01% | 7229 |
|
|
2018
Q2 | $4K | Buy |
+1,701
| New | +$4.33K | ﹤0.01% | 7583 |
|
|
2018
Q1 | – | Sell |
-1,866
| Closed | -$4K | – | 8285 |
|
|
2017
Q4 | $4K | Sell |
1,866
-2,677
| -59% | -$5.6K | ﹤0.01% | 7484 |
|
|
2017
Q3 | $10K | Buy |
+4,543
| New | +$10.1K | ﹤0.01% | 6906 |
|
|
2017
Q1 | – | Sell |
-2,208
| Closed | -$4K | – | 8106 |
|
|
2016
Q4 | $4K | Buy |
+2,208
| New | +$4.94K | ﹤0.01% | 7353 |
|
|
2016
Q1 | – | Sell |
-711
| Closed | -$2K | – | 8356 |
|
|
2015
Q4 | $2K | Buy |
+711
| New | +$1.71K | ﹤0.01% | 8047 |
|
|
2015
Q3 | – | Sell |
-1,475
| Closed | -$5K | – | 8728 |
|
|
2015
Q2 | $5K | Buy |
1,475
+671
| +83% | +$2.04K | ﹤0.01% | 7896 |
|
|
2015
Q1 | $3K | Sell |
804
-1,278
| -61% | -$4.11K | ﹤0.01% | 8360 |
|
|
2014
Q4 | $8K | Buy |
+2,082
| New | +$7.48K | ﹤0.01% | 8628 |
|
UBS Group's AHPI Position: Q1 2023 in Review
UBS Group sold out of Allied Healthcare Products (AHPI) in Q1 2023, closing a stake of 7,466 shares — an estimated $6.87K sold.
UBS Group first reported a position in AHPI in Q4 2014 and held it in 22 quarters. The position peaked at $23K in Q1 2020. 1 fund tracked by Wall St. Rank holds AHPI as of Q1 2023.
- UBS Group reported no remaining Allied Healthcare Products position as of Q1 2023 after selling out during the quarter.
- UBS Group sold 7,466 Allied Healthcare Products shares in Q1 2023, an estimated $6.87K.
- UBS Group first reported a position in Allied Healthcare Products in Q4 2014 and held it in 22 quarters.
- UBS Group's Allied Healthcare Products position peaked at $23K in Q1 2020.
- 1 fund tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2023.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.